Integra LifeSciences (IART) Tops Q1 EPS by 13c

Integra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.76, $0.13 better than the analyst estimate of $0.63. Revenue for the quarter came in at $233.7 million versus the consensus estimate of $229.69 million.

Integra LifeSciences sees FY2015 EPS of $3.15-$3.33, versus the consensus of $3.17. Integra LifeSciences sees FY2015 revenue of $965-980 million, versus the consensus of $972.3 million.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Nvidia underperforms peers as report sparks rack delay worries
• Tepper’s Appaloosa soars 32% in H1 on prescient memory-chip bets - report